<DOC>
	<DOCNO>NCT00780403</DOCNO>
	<brief_summary>The primary objective study determine whether child age 6-11 year prefer desloratadine RediTabs ( 2.5 mg ) market competitor ( Zyrtec® 5 mg Chewable Tablets ) . The secondary objective study compare acceptance two attribute , taste feeling mouth , desloratadine 2.5 mg RediTabs Zyrtec® 5 mg Chewable Tablets</brief_summary>
	<brief_title>Multi-Center , Pediatric , Open-Label , Preference Study Desloratadine 2.5 mg Reditab ( SCH34117 ) Zyrtec ® 5.0 mg Chewable Tablet Medications ( Study P04573 ) ( Completed )</brief_title>
	<detailed_description />
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Subject parent/guardian subject , demonstrate willingness participate study comply procedure sign write Informed Consent 611 year old , either sex , either race If female , subject premenarcheal Willing avoid eating , drinking , gum chewing , teeth brush one hour prior enrollment . Free clinically significant disease would interfere study evaluation , include allergic rhinitis respiratory infection . Able adhere dose visit schedule If female , subject pregnant , intend become pregnant study nursing . Subject use investigational product within 30 day prior enrollment . Subject follow clinical condition : history significant medical condition ( base reporting parent guardian ) : e.g. , diabetes , heart disease , liver disease , kidney disease , breathe problem , cough excessive phlegm , persistent chronic cough . Subject current medical condition , opinion Investigator designee , may interfere ability discriminate taste ( e.g. , common cold , sinus infection , bronchial infection , allergic rhinitis , etc. ) . Subject participate clinical study ( y ) . Subject part staff family member staff personnel directly involve study . Subject allergic sensitivity study drug excipients . Subject history allergic reaction prescription and/or counter ( OTC ) medication and/or food product . Subject use antihistamine within 24 hour prior taste outline Section 9.4.7 . Subject use sedative , tranquilizer , monoamine oxidase inhibitor drug .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>